FDA
-
-
-
-
-
-
-
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
-
-
-
-
-
-
-
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
-
-
-
-
-
-
Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

